MEDIC
ActiveSummary
MEDIC has been active since 1988 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €796,299 and a net result of €102,938. Equity is growing by ~26.8% per year across the filed fiscal years. Its solvency ranks better than 94% of 16754 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is < 0.1% (very low).
Checked score
Score 2025
Axes · tick = 2024
Profitability84▼-9
Solvency100=
Growth78=
Track record100
Bankruptcy probability, 12 months
< 0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €75,000 at 30 days acceptable
Liquidity ample (current ratio 17.88 against 11.7 in 2024; short-term debt: 3.2% and cash: 44.2% of total assets), and 3.2% of the assets are financed with debt.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
96.8%
Return on assets
12.5%
Age of the figures
9 mo
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 20-08-2026, 20 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filingsDeviation from the deadline
2025
20 d late
2024
19 d late
2023
30 d late
2022
42 d late
2021
27 d late
2020
31 d late
2019
31 d late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 29 days after the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
28-09-2026 today31-12-2026 close31-07-2027 deadline
History
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Is this your company? See how customers and banks see it.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2025, micro schema
In the rankings
#1 oldest company in Eghezée, Health and social work sector#2 company by equity in Eghezée, Health and social work sector#6 company by total assets in Eghezée, Health and social work sector
Equity
€796,299▲ 5.8%
2024 · €752,328
Total assets
€822,759▲ 4.0%
2024 · €790,918
Net result
€102,938▼ 32.9%
2024 · €153,506
Working capital
€446,691▲ 8.2%
2024 · €413,015
Trend over the years
Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings. Dashed line: the median.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20212022202320242025
Operating result€243,559▲ 77.1%€169,570▼ 30.4%€175,968▲ 3.8%€214,630▲ 22.0%€143,283▼ 33.2%
Net result€164,865above the sector's middle half▲ 69.2%€116,015above the sector's middle half▼ 29.6%€124,265above the sector's middle half▲ 7.1%€153,506above the sector's middle half▲ 23.5%€102,938within the sector's middle half▼ 32.9%
Equity€358,542within the sector's middle half▲ 85.1%€474,557above the sector's middle half▲ 32.4%€598,822above the sector's middle half▲ 26.2%€752,328above the sector's middle half▲ 25.6%€796,299above the sector's middle half▲ 5.8%
Total assets€428,747within the sector's middle half▲ 13.2%€600,866within the sector's middle half▲ 40.1%€622,036above the sector's middle half▲ 3.5%€790,918above the sector's middle half▲ 27.1%€822,759above the sector's middle half▲ 4.0%
Debt€70,205▼ 62.1%€126,309▲ 79.9%€23,214▼ 81.6%€38,590▲ 66.2%€26,460▼ 31.4%
Working capital€267,254above the sector's middle half▲ 201%€371,771above the sector's middle half▲ 39.1%€475,277above the sector's middle half▲ 27.8%€413,015above the sector's middle half▼ 13.1%€446,691above the sector's middle half▲ 8.2%
Solvency83.6%above the sector's middle half▲ 32.5pp79.0%within the sector's middle half▼ 4.6pp96.3%above the sector's middle half▲ 17.3pp95.1%above the sector's middle half▼ 1.1pp96.8%above the sector's middle half▲ 1.7pp
Current ratio4.81within the sector's middle half▲ 3.334.13within the sector's middle half▼ 0.6821.64above the sector's middle half▲ 17.5211.70above the sector's middle half▼ 9.9417.88above the sector's middle half▲ 6.18
Return on assets (ROA)38.5%above the sector's middle half▲ 12.7pp19.3%within the sector's middle half▼ 19.1pp20.0%within the sector's middle half▲ 0.7pp19.4%within the sector's middle half▼ 0.6pp12.5%within the sector's middle half▼ 6.9pp
Staff (FTE)1▲ 150%0.40.4=1.8▲ 350%
above
within
below
the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings.
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result falls in 2025; 2025 is 33% below 2024 and is the lowest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €822,759
Fixed assets
€349,608 ▲ 3.0%
Current assets
€473,151 ▲ 4.8%
Equity and liabilities €822,759
Equity
€796,299 ▲ 5.8%
Debt
€26,460 ▼ 31.4%
Debt's share of the balance-sheet total falls from 4.9% to 3.2%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€182,261▼
2024 · €239,798
Cash flow
€141,916▼
2024 · €178,674
Debt to equity
0.03▼
2024 · 0.05
ROE
12.9%▼
2024 · 20.4%
Interest coverage
93.60▼
2024 · 96.68
Debt ≤ 1 year
€26,460▼
2024 · €38,590
Income taxes
€42,534▼
2024 · €61,995
Staff costs
€51,957▲
2024 · €22,634
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Peer companies
Historical observationOf the 31,349 companies that looked in July 2024 the way this one looks now, 0.4% went bankrupt within 24 months and 93% are still going.
- Micro
- 20 years or older
- solvency 30% or more
- a profit of 5% of the balance sheet or more
0.4%
went bankrupt
5.9%
stopped otherwise
93%
still going
A further 0.2% stopped, but we cannot tell whether within those 24 months.
For this company itself Checked computes a bankruptcy probability of < 0.1% over twelve months; the group does not contradict it.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,662 companies of July 2024 its group's bankruptcy share. Expected: 1.5%; actually bankrupt within 24 months: 1.6%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.4% |
| 3 | 0.5% | 0.5% |
| 4 | 0.6% | 0.7% |
| 5 | 0.8% | 0.9% |
| 6 | 1.2% | 1.3% |
| 7 | 1.5% | 1.7% |
| 8 | 1.7% | 1.7% |
| 9 | 2.7% | 2.8% |
| 10 | 5.3% | 5.7% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 75% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 31,349 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
Annual accounts
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Non-recurring operating income76A | €0 | €20,000 | €0 | - | - | - |
| Remuneration, social security and pensions62 | €34,324 | €19,950 | €23,229 | €22,634 | €51,957 | ▲ 130% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €25,760 | €28,556 | €20,894 | €25,169 | €38,978 | ▲ 54.9% |
| Other operating charges640/8 | €3,863 | €3,613 | €4,001 | €4,830 | €4,743 | ▼ 1.8% |
| Gross operating margin9900 | €307,505 | €221,689 | €224,091 | €267,262 | €238,961 | ▼ 10.6% |
| Operating profit (loss)9901 | €243,559 | €169,570 | €175,968 | €214,630 | €143,283 | ▼ 33.2% |
| Financial income75/76B | €218 | €0 | €1,884 | €3,352 | €4,136 | ▲ 23.4% |
| Recurring financial income75 | €218 | €0 | €1,884 | €3,352 | €4,136 | ▲ 23.4% |
| Financial charges65/66B | €1,993 | €2,392 | €2,716 | €2,480 | €1,947 | ▼ 21.5% |
| Recurring financial charges65 | €1,993 | €2,392 | €2,716 | €2,480 | €1,947 | ▼ 21.5% |
| Profit (loss) for the period before taxes9903 | €241,783 | €167,178 | €175,135 | €215,501 | €145,472 | ▼ 32.5% |
| Income taxes67/77 | €76,918 | €51,162 | €50,870 | €61,995 | €42,534 | ▼ 31.4% |
| Profit (loss) for the period9904 | €164,865 | €116,015 | €124,265 | €153,506 | €102,938 | ▼ 32.9% |
| Transfer from tax-exempt reserves789 | €7,500 | €0 | - | - | - | - |
| Profit (loss) for the period to be appropriated9905 | €172,365 | €116,015 | €124,265 | €153,506 | €102,938 | ▼ 32.9% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €428,747 | €600,866 | €622,036 | €790,918 | €822,759 | ▲ 4.0% |
| Fixed assets21/28 | €91,288 | €110,164 | €123,738 | €339,313 | €349,608 | ▲ 3.0% |
| Tangible fixed assets22/27 | €91,163 | €110,039 | €123,293 | €338,868 | €349,163 | ▲ 3.0% |
| Land and buildings22 | €52,385 | €39,684 | €39,378 | €211,661 | €219,074 | ▲ 3.5% |
| Plant, machinery and equipment23 | €38,778 | €49,083 | €53,872 | €42,943 | €35,986 | ▼ 16.2% |
| Furniture and vehicles24 | €0 | €21,272 | €29,282 | €26,924 | €22,733 | ▼ 15.6% |
| Other tangible fixed assets26 | - | - | €761 | €57,340 | €71,371 | ▲ 24.5% |
| Financial fixed assets28 | €125 | €125 | €445 | €445 | €445 | = |
| Current assets29/58 | €337,459 | €490,702 | €498,298 | €451,605 | €473,151 | ▲ 4.8% |
| Amounts receivable within one year40/41 | €7,912 | €23,521 | €102,580 | €98,876 | €83,461 | ▼ 15.6% |
| Trade receivables40 | €7,912 | €1,900 | €1,900 | €0 | - | - |
| Other amounts receivable41 | €0 | €21,621 | €100,681 | €98,876 | €83,461 | ▼ 15.6% |
| Current investments50/53 | €1,000 | €1,000 | €1,000 | €1,000 | €1,000 | = |
| Cash at bank and in hand54/58 | €322,452 | €456,549 | €388,044 | €329,550 | €363,448 | ▲ 10.3% |
| Deferred charges and accrued income490/1 | €6,096 | €9,632 | €6,674 | €22,179 | €25,242 | ▲ 13.8% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €428,747 | €600,866 | €622,036 | €790,918 | €822,759 | ▲ 4.0% |
| Equity10/15 | €358,542 | €474,557 | €598,822 | €752,328 | €796,299 | ▲ 5.8% |
| Contributions10/11 | €12,400 | €12,400 | €12,400 | €12,400 | €12,400 | = |
| Reserves13 | €330,610 | €446,625 | €570,890 | €724,396 | €768,367 | ▲ 6.1% |
| Non-distributable reserves130/1 | €1,860 | €1,860 | €0 | - | - | - |
| Reserves not available under the articles1311 | €1,860 | €1,860 | €0 | - | - | - |
| Tax-exempt reserves132 | €0 | - | - | - | - | - |
| Distributable reserves133 | €328,750 | €444,765 | €570,890 | €724,396 | €768,367 | ▲ 6.1% |
| Profit (loss) carried forward14 | €15,532 | €15,532 | €15,532 | €15,532 | €15,532 | = |
| Amounts payable17/49 | €70,205 | €126,309 | €23,214 | €38,590 | €26,460 | ▼ 31.4% |
| Amounts payable within one year42/48 | €70,205 | €118,931 | €23,021 | €38,590 | €26,460 | ▼ 31.4% |
| Current portion of amounts payable after more than one year42 | €0 | - | - | - | - | - |
| Trade debts44 | €5,173 | €42,352 | €2,017 | €2,347 | €5,037 | ▲ 115% |
| Suppliers440/4 | €5,173 | €42,352 | €2,017 | €2,347 | €5,037 | ▲ 115% |
| Taxes, remuneration and social security45 | €47,483 | €45,540 | €21,004 | €36,243 | €21,423 | ▼ 40.9% |
| Taxes450/3 | €45,378 | €41,800 | €17,327 | €31,951 | €15,194 | ▼ 52.4% |
| Remuneration and social security454/9 | €2,106 | €3,740 | €3,678 | €4,292 | €6,229 | ▲ 45.1% |
| Other amounts payable47/48 | €17,548 | €31,039 | €0 | - | - | - |
| Accrued charges and deferred income492/3 | - | €7,378 | €193 | €0 | - | - |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €164,865 | €116,015 | €124,265 | €153,506 | €102,938 | ▼ 32.9% |
| + Depreciation and write-downs630 | €25,760 | €28,556 | €20,894 | €25,169 | €38,978 | ▲ 54.9% |
| Operating cash flow (approximation) | €190,625 | €144,571 | €145,159 | €178,674 | €141,916 | ▼ 20.6% |
| Investment in fixed assets (approximation) | - | -€47,432 | -€34,468 | -€240,744 | -€49,273 | ▲ 79.5% |
| Change in cash | - | €134,097 | -€68,505 | -€58,494 | €33,898 | ▲ 158% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
20-08
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema · 20 days late
2025
19-08
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 19 days late
2024
30-08
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 30 days late
2023
31-12
Financial
Liquidity times 5current ratio 21.64
Current ratio from 4.13 to 21.64; short-term debt falls from €118,931 to €23,021.
31-12
Financial
Equity above €500,000Eq €598,822 ▲26.2%
6 profitable years in a row build equity to €598,822.
11-09
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 42 days late
2022
27-08
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 27 days late
2021
31-12
Financial
Highest result since 2018net €164,865 ▲69.2%
Operating result €243,559, net result €164,865, both a record.
31-12
Financial
Liquidity triplescurrent ratio 4.81
Current ratio from 1.48 to 4.81; short-term debt falls from €185,220 to €70,205.
31-12
Financial
Equity above €200,000Eq €358,542 ▲85.1%
4 profitable years in a row build equity to €358,542.
31-08
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 31 days late
2020
31-08
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema · 31 days late
Show earlier events
2019
31-12
Financial
Weakest financial yearnet €58,967 ▼3.4%
Net result drops to €58,967, the lowest in the series; recovery starts the following year.
31-12
Financial
Equity above €200,000Eq €232,544 ▲34%
2 profitable years in a row build equity to €232,544.
30-08
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema · 30 days late
2018
28-08
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema · 28 days late
2017
25-07
NBB filing
Annual accounts filed
fiscal year 2016 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 5 acts read
About the unread acts
We know of 5 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
5 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Eghezée · 1 establishment unit since 1988
Ground area
4,583 m²
Building footprint
154 m²
Parcel 92001C0040/00B000, Wallonia. Linked by address, not a title deed.
2
companies at this address
See who is registered here
1 establishment unit
Route de Gembloux,Aische 195, 5310 Eghezée
since 19882.243.537.051
1 parcel
Wallonia
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 92001C0040/00B000 | Wallonia | 4,583 m² | 1 · 154 m² | - |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
LIBAGYN
BE 0881.998.828
Sint-Lambrechts-Woluwe · Eq €795,636
Dr. K. De Crem
BE 0880.056.254
Aalter · Eq €797,219
Cabinets Médicaux Vieusart-Limal
BE 0836.249.569
Chaumont-Gistoux · Eq €795,297
DR. MARC SCHOUTEDEN
BE 0478.390.736
Hechtel-Eksel · Eq €795,064
LES DOCTEURS CHARLIER-MEDECINE GENERALE
BE 0836.479.696
Tenneville · Eq €794,476
Of 9,128 companies in sector 86210 we hold annual accounts for 6,335. 4,406 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded11-10-1988
Fiscal year end31-12
Activities, NACEBEL 2025
86210General medical practice
Contact
E-mail
philippetassart@gmail.com
Phone
081656160
Phone
0477/67.49.36Eghezée
E-invoicing
Reachable via Peppol
Peppol ID
0208:0435541678
Registered
08-01-2026
Register as of 27 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.